Trials / Withdrawn
WithdrawnNCT00780637
Brachial Artery t-PA Release in Heart Transplant Recipients
Characterization of Brachial Arterial t-PA Release, Vasodilator Function, and Vascular Compliance and Correlation With Fibrinolytic Balance, Oxidative Stress, and Inflammation Measures in Heart Transplant Recipients (SCCOR Project 1, Aim 3C)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Bradykinin stimulates t-PA release from intact vessels, but not from endothelial cells in culture. It has been proposed that the nerves of blood vessels are the source of bradykinin stimulated t-PA release. In order tho test this hypothesis, we intend to infuse bradykinin into the brachial (arm) artery and the coronary arteries of heart transplant recipients and control subjects. This is because heart transplant recipients do not have nerves to their coronary arteries. This protocol studies the effects of bradykinin on t-PA release in the forearm of transplant recipients. The brachial artery has intact nerves. Separate protocols address coronary artery infusions in healthy subjects and transplant recipients and forearm infusions in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bradykinin | Patients receive 0, 10, 20, and 40 ng/100cc forearm volume/min of bradykinin intrabrachial. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-01-01
- Completion
- 2011-05-01
- First posted
- 2008-10-27
- Last updated
- 2016-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00780637. Inclusion in this directory is not an endorsement.